<p>The liver, spleen and lung levels of <sup>125</sup>I labeled anti-PECAM-1 IONPs measured 10 min after intra-arterial infusion in rats, expressed as the percentage of injected dose (%ID, 10 mg/kg). * Significantly different compared to IgG IONPs. (N = 3, mean ± SD)</p
<p>At day 90 post-immunization, plasma levels of IL-10 (A), IL-4 (B), MCP-1 (C) and OPG (D) did not ...
<p>Plasma concentrations of ASP4058 and blood concentration of fingolimod phosphate during and after...
The identification of clinically meaningful and predictive models of disposition kinetics for cancer...
<p>The blood (A) and brain (B) levels of <sup>125</sup>I labeled anti-PECAM-1-IONPs after intra-arte...
<p>Anti-PECAM-1 IONP (0.05 mg/ml), IgG IONP (0.05 mg/ml) and LY (100 µM) flux across hCMEC/D3 cells ...
<p>Organ distribution of rhodamine-labeled ELP1, SynB1-ELP1, or Bac-ELP1 was determined 4 h after IV...
Rats were injected via the tail vein with negative control (white bar, n = 3), anti-TfR antibody OX-...
<p>Rats received saline, 10/kg IgG IONPs, or 10 mg/kg anti-PECAM-1 IONPs and were terminated 10 min ...
<p>Values are means ± S.E.M. of 6–8 determinations using different rats, carried out in duplicate. D...
rat tissues estimated by continuous infusion. Am. J. Physiol. 266 (lieart Circ. Physiol. 3%: H212-H2...
<p>Percentages based on raw values from <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
The ratio of the pharmacokinetic parameters comparing NHPs to rats after subcutaneous administration...
<p>Nanoparticles (80 μg/g body mass) were systemically administered by tail vein injection in NSG mi...
<p>(a) A densitometric analysis of samples from control (n = 4), VDD (n = 6), TDF (n = 6) and VDD+TD...
To estimate the absorbed dose in normal organs and inflammated tissue following i.v. administration ...
<p>At day 90 post-immunization, plasma levels of IL-10 (A), IL-4 (B), MCP-1 (C) and OPG (D) did not ...
<p>Plasma concentrations of ASP4058 and blood concentration of fingolimod phosphate during and after...
The identification of clinically meaningful and predictive models of disposition kinetics for cancer...
<p>The blood (A) and brain (B) levels of <sup>125</sup>I labeled anti-PECAM-1-IONPs after intra-arte...
<p>Anti-PECAM-1 IONP (0.05 mg/ml), IgG IONP (0.05 mg/ml) and LY (100 µM) flux across hCMEC/D3 cells ...
<p>Organ distribution of rhodamine-labeled ELP1, SynB1-ELP1, or Bac-ELP1 was determined 4 h after IV...
Rats were injected via the tail vein with negative control (white bar, n = 3), anti-TfR antibody OX-...
<p>Rats received saline, 10/kg IgG IONPs, or 10 mg/kg anti-PECAM-1 IONPs and were terminated 10 min ...
<p>Values are means ± S.E.M. of 6–8 determinations using different rats, carried out in duplicate. D...
rat tissues estimated by continuous infusion. Am. J. Physiol. 266 (lieart Circ. Physiol. 3%: H212-H2...
<p>Percentages based on raw values from <a href="http://www.plosone.org/article/info:doi/10.1371/jou...
The ratio of the pharmacokinetic parameters comparing NHPs to rats after subcutaneous administration...
<p>Nanoparticles (80 μg/g body mass) were systemically administered by tail vein injection in NSG mi...
<p>(a) A densitometric analysis of samples from control (n = 4), VDD (n = 6), TDF (n = 6) and VDD+TD...
To estimate the absorbed dose in normal organs and inflammated tissue following i.v. administration ...
<p>At day 90 post-immunization, plasma levels of IL-10 (A), IL-4 (B), MCP-1 (C) and OPG (D) did not ...
<p>Plasma concentrations of ASP4058 and blood concentration of fingolimod phosphate during and after...
The identification of clinically meaningful and predictive models of disposition kinetics for cancer...